Machine learning of data from 3 well-known heart studies shows a decline in heart failure risk from drinking at least 1 cup of caffeinated coffee each day.
Machine learning of data from 3 well-known heart studies shows a decline in heart failure risk from drinking at least 1 cup of coffee each day, report investigators in Circulation: Heart Failure.
Similar results were not seen for individuals who consumed decaffeinated coffee, among whom the risk of heart failure rose significantly, at least in the Framingham Heart Study (FHS). For the present analysis, coffee intake was categorized into 0, 1, 2, or 3 cups daily.
“While smoking, age, and high blood pressure are among the most well-known heart disease risk factors, unidentifed risk factors for heart disease remain,” particularly for developing heart failure, said David P. Kao, MD, senior author of the study, in a statement. One of these risks factors is coffee, the benefits of which constitute an ongoing debate due to self-reported data and inconsistent diet assessment.
Dietary data from Framingham were analyzed via machine learning, through the American Heart Association’s Precision Medicine Platform, and then compared with data from the Atherosclerosis Risk in Communities (ARIC) study and the Cardiovascular Health Study (CHS)—all prospective longitudinal cohort studies. Two large plusses of the studies included in this analysis is that they all had at least 10 years of follow-up and collectively covered more than 21,000 US adults (n = 2732 from Framingham, 14925 from ARIC, and 3704 from CHS) 30 years and older.
Thirty-five common risk factors were identified by the authors as being in the top 20% for coronary heart disease (CHD), heart failure, and stroke. They further analyzed dietary factors, including whole milk, red meat, and caffeinated and decaffeinated coffee, “given their potential for behavior modification.” Of these, “coffee consumption was the only factor that remained significantly associated with any of the outcomes.”
Analyses revealed decreased risks of both heart failure and stroke with increased caffeinated coffee intake:
Similar results were not seen for CHD (P = .21) or cardiovascular disease (CVD) (P = .59).
The authors then adjusted for FHS CVD risk, and again, increased caffeinated coffee intake had a significant link to drop in heart failure risk (HR, 0.95 cup/day; 95% CI, 0.90-1.00; P = .03).
Stratifying results via univariable and multivariable analysis showed a decreased heart failure risk in CHS (HR, 0.86 cup/day; 95% CI, 0.78-0.96; P = .005) and ARIC (HR, 0.98 cup/day; 95% CI, 0.96-0.99; P = .048). After adjusting for FHS score, this association remained in CHS (HR, 0.88 cup/day; 95% CI, 0.79-0.97; P = .01), while where was a trend toward multivariable association in ARIC (HR, 0.98 cup/day; 95% CI, 0.96-1.00; P = .06).
Additional analyses of caffeinated (FHS, CHS, and ARIC) vs decaffeinated (FHS and CHS) coffee consumption and heart failure risk resulted in a significant association for greater risk in FHS (HR, 1.10 cup/day; 95% CI, 1.03-1.17; P = .004) with decaffeinated coffee intake.
The authors highlighted that whereas previous studies have focused on composite CVD outcomes, few have attempted to study caffeine intake and how it affects risk of heart failure. “This analysis expands those findings to include the relationship between decreased risk of [heart failure] and higher coffee consumption,” they noted.
“It remains possible that coffee consumption is a marker or proxy for another behavior or dietary factor that reduces heart failure,” they continued. “Consequently, intentional or prescribed increase in coffee intake for the purposes of reducing heart failure risk cannot be recommended based on our results.”
They recommend that future studies examine coffee, and caffeine, to draw a clearer link between amount consumed—because coffee is “pervasive in modern society, [but] has high potential for dietary modification”—their roles, and potential mechanisms of action as risk factors for heart failure.
Reference
Stevens LM, Linstead E, Hall JL, Kao DP. Association between coffee intake and incident heart failure risk. Circ Heart Fail. Published online February 9, 2021. doi: 10.1161/CIRCHEARTFAILURE.119.006799
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Strategies Needed to Address Physical Activity Before, After CVD Events
August 1st 2025Black women had lower moderate-to-vigorous intensity physical activity scores when compared with Black and White men and their White female counterparts, highlighting the need for support across patient subgroups.
Read More
AI-Enhanced ECG Expands Access, Reduces Costs for Patients
July 25th 2025An AI model significantly outperformed cardiologists when reviewing ECGs of structural heart disease and may potentially be a step towards increased access and lower costs for early detection of conditions like heart failure and valvular heart disease.
Read More